Virtual Reality Sickness Questionnaire: Psychometrics in Stroke Patients
NCT ID: NCT07297862
Last Updated: 2025-12-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
50 participants
OBSERVATIONAL
2025-07-16
2026-08-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Motion Sickness Assessment Questionnaire (MSAQ) and the Simulator Sickness Questionnaire (SSQ), which evaluates the symptoms under four titles (gastrointestinal, central, peripheral and fatigue), are used in the literature to evaluate this effect. However, these questionnaires may not be sufficient to assess the MS symptoms that develop after virtual reality (VR) applications. Because MS symptoms occur differently in VR and simulation systems. For this reason, the Virtual Reality Sickness Questionnaire (VRSQ) was developed by Kim and his colleagues to evaluate the symptoms that occur after virtual reality. The Turkish validity and reliability of the VRSQ, which consists of 9 questions, was also conducted by Cetin and his friends.
The aim of this study to investigate how virtual reality affects physiological factors (heart rate, blood pressure) in stroke patients and to evaluate the psychometric properties of the Virtual Reality Sickness Questionnaire in assessing VR-induced motion sickness.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stroke Group
Roller Coaster application
Participants will experience a 15-minute roller coaster virtual reality (VR) for three consecutive days, once a day. During this study, the virtual reality application will be performed while sitting in a chair and while fixed to the chair. The practitioner will be present with the participant throughout the VR application.
Healthy Group
Roller Coaster application
Participants will experience a 15-minute roller coaster virtual reality (VR) for three consecutive days, once a day. During this study, the virtual reality application will be performed while sitting in a chair and while fixed to the chair. The practitioner will be present with the participant throughout the VR application.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Roller Coaster application
Participants will experience a 15-minute roller coaster virtual reality (VR) for three consecutive days, once a day. During this study, the virtual reality application will be performed while sitting in a chair and while fixed to the chair. The practitioner will be present with the participant throughout the VR application.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. A minimum score of 24 on the Standardised Mini Mental Test (SMMT), 2.18-80 years old,
3. showing symptoms of MS with a minimum score of 10 on the Virtual Reality Sickness Questionnaire
4. Titmus test result of 3552 arc/s
5. Not having neglect syndrome
1\. A minimum score of 24 on the Standardised Mini Mental Test (SMMT), 2.18-80 years old, 3. showing symptoms of MS with a minimum score of 10 on the Virtual Reality Sickness Questionnaire 4. Titmus test result of 3552 arc/s
Exclusion Criteria
2. Presence of a diagnosis of neurological disease other than stroke,
3. Presence of a history of previous stroke,
4. Complete or partial loss of vision in one eye,
5. Previous use of Virtual Reality
6. Having diseases affecting the vestibular system such as Vertigo, Benign Paroxysmal Vertigo, Meniere's
1. Not volunteering for the study,
2. Presence of a diagnosis of neurological disease,
3. Complete or partial loss of vision in one eye,
4. Previous use of Virtual Reality
5. Having diseases affecting the vestibular system such as Vertigo, Benign Paroxysmal Vertigo, Meniere's
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abant Izzet Baysal University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Beyzanur ŞENTÜRK
Research Assistant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Abant Izzet Baysal University
Bolu, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AIBU-FTR-BS-001
Identifier Type: -
Identifier Source: org_study_id